Blog - biocrates life sciences ag

Carnitine – Metabolite of the month

Metabolite of the month is your sneak peek into the world of metabolomics. This month we look at carnitine #loveyourmetabolites

Elevated serum bile acid levels contribute to NASH-HCC

Higher serum bile acid levels and an altered gut microbiome contribute to fibrogenesis, liver injury, and tumorigenesis in cirrhotic and noncirrhotic NASH-HCC.

Mitochondria’s role in clinical depression

What does brain activity look like after anti-depressant treatment and what is the basis for prescribing serotonin re-uptake inhibitors in the first place?

Gut microbiota and statins

Metabolomics and 16S rRNA profiling uncover the crosstalk between gut microbiota and statins efficacy that can hide behind inter-individual variability.

Is Alzheimer’s a metabolic disease?

Alzheimer’s disease (AD) has many facets. Metabolomics supports Alzheimer’s early diagnosis and research on the treatment of AD.

Lipidomics in cardiac patients after the Fontan procedure

Lipidomics reveals long-term effects of palliative surgeries in Fontan patients after cardiac function is restored.

Therapy response monitoring in infectious diseases

Monitoring COVID-19 patient’s pathophysiology using metabolomics can lead to early detection of therapy response, opening an avenue to precision medicine.

Metabolomics and COVID-19

Monitoring COVID-19 patient’s pathophysiology might lead to early detection of therapy response, opening an avenue to precision medicine. Metabolomics is a tool to support these efforts.